Journal
BLOOD
Volume 133, Issue 10, Pages 1031-1038Publisher
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2018-10-844639
Keywords
-
Categories
Funding
- Dutch Cancer Society (KWF Kankerbestrijding) [EMCR 2016-10488, 2017-11092]
Ask authors/readers for more resources
Myelodysplastic syndrome (MDS) is characterized by bone marrow failure and a strong propensity for leukemic evolution. Somatic mutations are critical early drivers of the disorder, but the factors enabling the emergence, selection, and subsequent leukemic evolution of these leukemia-poised clones remain incompletely understood. Emerging data point at the mesenchymal niche as a critical contributor to disease initiation and evolution. Disrupted inflammatory signaling from niche cells may facilitate the occurrence of somatic mutations, their selection, and subsequent clonal expansion. This review summarizes the current concepts about niche-facilitated bone marrow failure and leukemic evolution, their underlying molecular mechanisms, and clinical implications for future innovative therapeutic targeting of the niche in MDS.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available